• NYSE
  • Contact
  • Insights
Episode 76

QIAGEN's Peer Schatz on the Molecular Revolution

36 minutes · January 3, 2019

Peer Schatz

Scientific breakthroughs depend on the development and deployment of cutting edge tools. One of the companies that laboratories across the globe turn to for testing solutions is QIAGEN (NYSE:QGEN). Peer Schatz, QIAGEN’s CEO, gave Inside the ICE House a masterclass on how the company is working with the science community to create the tests and equipment needed for infectious diseases control; cancer prevention, personalized medicine, and much more.

Podcast Archive

Subscribe to episodes

  • Listen on Apple Podcasts
  • Listen on Stitcher
  • Listen on Google Play Music
  • Spotify
  • Listen on Himalaya
  • RSS

Information contained in this podcast was obtained in part from publicly available sources, and not independently verified. Neither ICE nor its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the information and do not sponsor, approve, or endorse any of the content herein, all of which is presented solely for informational and educational purposes. Nothing herein constitutes an offer to sell, a solicitation of an offer to buy any security, or a recommendation of any security or trading practice.